Author | Jill Van Den Bos

Articles

Formulary Additions: The Big Picture

Pharmaceutical Executive

Article

To get along with the CFO, drug companies need to express more data in units that a health plan can integrate into its own internal actuarial analysis. The financial decision makers at a health plan want to know how a new drug affects the value of expected claims on the whole.